{"id":11341,"date":"2022-07-01T20:33:33","date_gmt":"2022-07-02T00:33:33","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/advances-in-bladder-cancer-immunotherapy-with-dr-arjun-balar\/"},"modified":"2022-07-14T16:07:10","modified_gmt":"2022-07-14T20:07:10","slug":"advances-in-bladder-cancer-immunotherapy-with-dr","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/advances-in-bladder-cancer-immunotherapy-with-dr","title":{"rendered":"Advances in Bladder Cancer Immunotherapy, with Dr. Arjun Balar"},"content":{"rendered":"<p><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/WF5xXFASfuE\" width=\"560\"><\/iframe><\/p>\n<p>Bladder cancer patients in the U.S. have seen a number of recent FDA approvals of different immunotherapies to treat the disease.<\/p>\n<p>In this webinar for patients and caregivers, Dr. Arjun Balar of the NYU Langone Medical Center in New York, NY, discusses the latest research and developments in bladder cancer immunotherapy. This webinar was recorded Friday, May 19, 2017.<\/p>\n<p>The &quot;Cancer Immunotherapy and You&quot; webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, Genentech, Regeneron, and Advaxis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Arjun Balar of the NYU Langone Medical Center&nbsp;discusses the latest research and developments in bladder cancer immunotherapy.<\/p>\n","protected":false},"featured_media":5778,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11341","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Advances in Bladder Cancer Immunotherapy<\/title>\n<meta name=\"description\" content=\"Dr. Arjun Balar of the NYU Langone Medical Center\u00a0discusses the latest research and developments in bladder cancer immunotherapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advances in Bladder Cancer Immunotherapy\" \/>\n<meta property=\"og:description\" content=\"Dr. Arjun Balar of the NYU Langone Medical Center\u00a0discusses the latest research and developments in bladder cancer immunotherapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:07:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c927c936-8e67-4473-a6d6-cb0280e0f8d4.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Advances in Bladder Cancer Immunotherapy\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Arjun Balar of the NYU Langone Medical Center\u00a0discusses the latest research and developments in bladder cancer immunotherapy.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c927c936-8e67-4473-a6d6-cb0280e0f8d4.png\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr\",\"name\":\"Advances in Bladder Cancer Immunotherapy\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f933ff08-db20-4b39-8880-1d9d054d2f32.png\",\"datePublished\":\"2022-07-02T00:33:33+00:00\",\"dateModified\":\"2022-07-14T20:07:10+00:00\",\"description\":\"Dr. Arjun Balar of the NYU Langone Medical Center\u00a0discusses the latest research and developments in bladder cancer immunotherapy.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f933ff08-db20-4b39-8880-1d9d054d2f32.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f933ff08-db20-4b39-8880-1d9d054d2f32.png\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Advances in Bladder Cancer Immunotherapy, with Dr. Arjun Balar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Advances in Bladder Cancer Immunotherapy","description":"Dr. Arjun Balar of the NYU Langone Medical Center\u00a0discusses the latest research and developments in bladder cancer immunotherapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr","og_locale":"es_ES","og_type":"article","og_title":"Advances in Bladder Cancer Immunotherapy","og_description":"Dr. Arjun Balar of the NYU Langone Medical Center\u00a0discusses the latest research and developments in bladder cancer immunotherapy.","og_url":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:07:10+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c927c936-8e67-4473-a6d6-cb0280e0f8d4.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Advances in Bladder Cancer Immunotherapy","twitter_description":"Dr. Arjun Balar of the NYU Langone Medical Center\u00a0discusses the latest research and developments in bladder cancer immunotherapy.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/c927c936-8e67-4473-a6d6-cb0280e0f8d4.png","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr","url":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr","name":"Advances in Bladder Cancer Immunotherapy","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f933ff08-db20-4b39-8880-1d9d054d2f32.png","datePublished":"2022-07-02T00:33:33+00:00","dateModified":"2022-07-14T20:07:10+00:00","description":"Dr. Arjun Balar of the NYU Langone Medical Center\u00a0discusses the latest research and developments in bladder cancer immunotherapy.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f933ff08-db20-4b39-8880-1d9d054d2f32.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/f933ff08-db20-4b39-8880-1d9d054d2f32.png","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/advances-in-bladder-cancer-immunotherapy-with-dr#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Advances in Bladder Cancer Immunotherapy, with Dr. Arjun Balar"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/5778"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11341"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11341"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11341"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11341"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11341"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11341"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}